Investor Presentaiton slide image

Investor Presentaiton

Amsterdam Paris 304 km 198 km An integrated R&D and manufacturing platform Specialized pharmaceutical ecosystem, to take products from POC to market 15,000 m² state-of-the art facilities Dedicated R&D and production areas Ability to handle high potent and complex developments Pilot, clinical & commercial batches GMP Standards compliance Ideally located, at the intersection of major European biopharma clusters mithroodmo Liège Frankfurt 228 km Strategy for the CDMO is to leverage our unique expertise in polymers (long-acting, implants, vaginal rings) and injectables for high value- added commercial projects and products Mithra Investor Presentation - November 2023 30
View entire presentation